Medwave: FDA OKs sensor-based blood pressure monitor

By Lisa Kerner

Charlotte, N.C., Sept. 20 - Medwave Inc. received Food and Drug Administration clearance to market Fusion, its non-invasive sensor-based blood pressure with vital signs options monitor.

The Danvers, Mass., medical device company also recently launched Primo, its portable, handheld blood pressure monitor used in hospitals and clinics nationwide.

Both Fusion and Primo can accurately monitor patients with 11 cm to 22 cm wrist sizes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.